# CLOTRIMAZOLE
> **ANDA216569** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2023-10-16
## Drug
- **FDA Application Number:** ANDA216569
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLOTRIMAZOLE
- **Generic name:** CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%
- **Active ingredients:** CLOTRIMAZOLE
- **Dosage form:** SOLUTION
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** Allegis Holdings, LLC
- **First approval:** 2023-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216569)
---
*MORVS · CC0 1.0*